1062 related articles for article (PubMed ID: 18951936)
21. Inhibition of glutamate release by bupropion in rat cerebral cortex nerve terminals.
Lin TY; Yang TT; Lu CW; Wang SJ
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):598-606. PubMed ID: 21216268
[TBL] [Abstract][Full Text] [Related]
22. HDT-1, a new synthetic compound, inhibits glutamate release in rat cerebral cortex nerve terminals (synaptosomes).
Wang SJ; Chou SH; Kuo YC; Chou SS; Tzeng WF; Leu JY; Huang RF; Liew YF
Acta Pharmacol Sin; 2008 Nov; 29(11):1289-95. PubMed ID: 18954522
[TBL] [Abstract][Full Text] [Related]
23. Astaxanthin inhibits glutamate release in rat cerebral cortex nerve terminals via suppression of voltage-dependent Ca(2+) entry and mitogen-activated protein kinase signaling pathway.
Lin TY; Lu CW; Wang SJ
J Agric Food Chem; 2010 Jul; 58(14):8271-8. PubMed ID: 20593829
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of glutamate release by fluspirilene in cerebrocortical nerve terminals (synaptosomes).
Wang SJ
Synapse; 2002 Apr; 44(1):36-41. PubMed ID: 11842444
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes).
Wang SJ; Wang KY; Wang WC
Neuroscience; 2004; 125(1):191-201. PubMed ID: 15051158
[TBL] [Abstract][Full Text] [Related]
26. An investigation into the effect of the type IV phosphodiesterase inhibitor rolipram in the modulation of glutamate release from rat prefrontocortical nerve terminals.
Wang SJ
Synapse; 2006 Jan; 59(1):41-50. PubMed ID: 16247764
[TBL] [Abstract][Full Text] [Related]
27. Memantine depresses glutamate release through inhibition of voltage-dependent Ca2+ entry and protein kinase C in rat cerebral cortex nerve terminals: an NMDA receptor-independent mechanism.
Lu CW; Lin TY; Wang SJ
Neurochem Int; 2010 Sep; 57(2):168-76. PubMed ID: 20493916
[TBL] [Abstract][Full Text] [Related]
28. Src family tyrosine kinases differentially modulate exocytosis from rat brain nerve terminals.
Baldwin ML; Cammarota M; Sim AT; Rostas JA
Neurochem Int; 2006 Jul; 49(1):80-6. PubMed ID: 16500731
[TBL] [Abstract][Full Text] [Related]
29. mGluR7 inhibits glutamate release through a PKC-independent decrease in the activity of P/Q-type Ca2+ channels and by diminishing cAMP in hippocampal nerve terminals.
Martín R; Torres M; Sánchez-Prieto J
Eur J Neurosci; 2007 Jul; 26(2):312-22. PubMed ID: 17650109
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms of glutamate release elicited in rat cerebrocortical nerve endings by 'pathologically' elevated extraterminal K+ concentrations.
Raiteri L; Zappettini S; Milanese M; Fedele E; Raiteri M; Bonanno G
J Neurochem; 2007 Nov; 103(3):952-61. PubMed ID: 17662048
[TBL] [Abstract][Full Text] [Related]
31. N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus.
Luccini E; Musante V; Neri E; Raiteri M; Pittaluga A
J Neurosci Res; 2007 Dec; 85(16):3657-65. PubMed ID: 17671992
[TBL] [Abstract][Full Text] [Related]
32. Cyclooxygenase 2 inhibitor celecoxib inhibits glutamate release by attenuating the PGE2/EP2 pathway in rat cerebral cortex endings.
Lin TY; Lu CW; Wang CC; Huang SK; Wang SJ
J Pharmacol Exp Ther; 2014 Oct; 351(1):134-45. PubMed ID: 25047516
[TBL] [Abstract][Full Text] [Related]
33. Aspartate release from rat hippocampal synaptosomes.
Bradford SE; Nadler JV
Neuroscience; 2004; 128(4):751-65. PubMed ID: 15464283
[TBL] [Abstract][Full Text] [Related]
34. Modulation of presynaptic glucocorticoid receptors on glutamate release from rat hippocampal nerve terminals.
Wang CC; Wang SJ
Synapse; 2009 Sep; 63(9):745-51. PubMed ID: 19484722
[TBL] [Abstract][Full Text] [Related]
35. Facilitation of glutamate release from rat cerebrocortical glutamatergic nerve terminals (synaptosomes) by phosphatidylserine and phosphatidylcholine.
Yang TT; Wang SJ
Synapse; 2009 Mar; 63(3):215-23. PubMed ID: 19072841
[TBL] [Abstract][Full Text] [Related]
36. Tanshinone IIA, a constituent of Danshen, inhibits the release of glutamate in rat cerebrocortical nerve terminals.
Lin TY; Lu CW; Huang SK; Wang SJ
J Ethnopharmacol; 2013 May; 147(2):488-96. PubMed ID: 23542145
[TBL] [Abstract][Full Text] [Related]
37. Vitamin B2 inhibits glutamate release from rat cerebrocortical nerve terminals.
Wang SJ; Wu WM; Yang FL; Hsu GS; Huang CY
Neuroreport; 2008 Aug; 19(13):1335-8. PubMed ID: 18695519
[TBL] [Abstract][Full Text] [Related]
38. Cellular mechanisms of acute decrease of glutamate release induced by raloxifene in rat cerebral cortex.
Hung KL; Wang CC; Wang SJ
Neuropharmacology; 2011; 61(1-2):293-304. PubMed ID: 21536054
[TBL] [Abstract][Full Text] [Related]
39. Partial compensation for N-type Ca(2+) channel loss by P/Q-type Ca(2+) channels underlines the differential release properties supported by these channels at cerebrocortical nerve terminals.
Ladera C; Martín R; Bartolomé-Martín D; Torres M; Sánchez-Prieto J
Eur J Neurosci; 2009 Mar; 29(6):1131-40. PubMed ID: 19302149
[TBL] [Abstract][Full Text] [Related]
40. Ginkgolide B, a constituent of Ginkgo biloba, facilitates glutamate exocytosis from rat hippocampal nerve terminals.
Wang SJ; Chen HH
Eur J Pharmacol; 2005 May; 514(2-3):141-9. PubMed ID: 15910800
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
